Infection with human T-cell leukemia virus type-I (HTLV-1
the virus remains latent in the normal host with expression of viral genes limited to the immediate-early gene complex.14 The immediate-early gene complex of HCMV codes for at least two transactivation proteins, IE-1 and IE-2.I8 IE-2 gene product(s) have been shown to be potent transactivators of heterologous promoters, including the long terminal repeat (LTR) of HIV-1 in both Hela and B-cell line^.^^'^ Furthermore, HCMV and HIV-1 dual infection of HOS cells enhances expression of both viruses." We examined the interaction between the immediate-early region 2 gene product(s) and the LTR of HTLV-I.
We have studied the ability of HCMV IE-2 gene product(s) to modulate the expression of the bacterial gene chloramphenicol acetyl transferase (CAT) that is driven by the HTLV-I LTR. We report in this study that the HCMV IE-2 gene product represses the HTLV-I promoter both in HTLV-I-producing cell lines where there is expression of the transactivating protein tar as well as in uninfected primary human peripheral blood lymphocytes (PBL) and cloned lymphocyte cell lines. By analysis of HTLV-I 5' and 3' LTR deletion mutants, a single region responsive to the IE-2 protein could not be identified. However, RNase protection assays indicated that this response was at least in part mediated at the RNA level.
MATERIALS AND METHODS

Cells.
Established HTLV-I-producing T-cell lines, MT-2'" and HUT-102," as well as the uninfected Jurkat T-cell line, were maintained in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS), 100 U/mL of penicillin, 100 FgImL of streptomycin, and 2 mmol/L glutamine. PBL were prepared from whole fresh blood. Mononuclear cells were isolated by centrifugation over Ficoll-Hypaque (Pharmacia, Pleasant Hill, CA) cultured for 3 days in RPMI 1640 medium containing 20% FCS, 100 U/mL penicillin, 100 pg/mL streptomycin, 2 mmol/L glutamine, 1% phytohemagglutinin, and recombinant interleukin-2 (30 UlmL). The nonadherent cells were used for transfection studies.
HTLV-I 3' deletion mutants were constructed from the pU3RCAT plasmid containing the U3, R, and 40 bases of the U5 region of the intact HTLV-I LTR." By the polymerase chain reaction method, fragments of 500-to 700-bp length were synthesized, the fragments digested with the restriction enzymes XhoI and HindIII, and ligated into anXhoI-and HindIII-digested pU3RCAT vector. The For personal use only. on October 30, 2017 . by guest www.bloodjournal.org From sense oligonucleotide used for amplification of the specific fragments was the same (5'CTAACTCGAGCmCATAGTTTA-CATCTC3'). T h e antisense primers were as follows: 3B(5 'TAGCAAGCTTGCGGGCGCGTGAAGGAGAGA3 '); 3C(5 'TAGCAAGCTTCGCGACTCAACGGCGTGGA3'); 3D(5 'TAGCAAGCTTTTAAACTTACCTAGACGGCG3'); 3E(5'TAGCAAGCTTGGCTGAGTCTAGGTAGGCTC3'); and 3F( S'TAGCAAGCTTCAGAAAACGAAACAAAGACG3').
Construction of HTLV-I LTR-CAT deletion mutants.
HTLV-I LTR 5' deletion mutants were a gift from John Brady (National Cancer Institute, Bethesda, MD).U Fragments of 200 to 700 bp were ligated into the pCAT3MZ4 vector at the unique BgDI site.
HCMV IE-2 activity was obtained using plasmid pHD101-4 (pHD4), a gift from Eng-Shang Huang and Michelle Davis (University of North Carolina, Chapel This plasmid expresses the IE-2 gene product(s) under the control of the HCMV major immediate-early promoter. The IE-1 gene product is not expressed. A control plasmid designated pHD4-R was constructed by placing exon 5 in the antisense orientation using theBamHI site on either end of this exon. The plasmid pRC/CMV (pCMV) contains only the immediate-early promoter region in a pUC vector (Invitrogen, San Diego, CA) and was used as a control plasmid in all transfection studies.
The plasmids pCD15CAT and pCD12-CAT were a gift from Steven Josephs (Baxter, Chicago, IL). The plasmid pCD15-CAT contains the HIV-1 IIIB U3-R region of the LTR as well as a portion of nef cloned into the Hind111 site of pSVoCAT. The plasmid pCD12-CAT is an identical construct without the nef sequence^.^' The plasmid ptat contains the tat coding sequence driven by the HIV-1 LTR.% MT-2, HUT-102, PBL, and Jurkat cells were transfected by electroporation with the BioRad Gene Pulser (Richmond, CA)." The cells were washed once with growth media and resuspended at a concentration of 4 x lo7 cells/mL in ice-cold medium. Fifty micrograms of DNA was added to 0.25 mL of cell suspension (containing 1 x lo7 cells), mixed gently, and incubated on ice for 10 minutes. A single pulse of 960 microfarads, 250 V was applied to each sample, followed by an additional 10 minutes of incubation on ice. Cells were resuspended in 10 mL of fresh growth media and incubated at 37°C. Twenty-four hours after electroporation, cells were harvested for CAT assay.
Cell extracts were prepared by standard methods and assayed for CAT a~tivity.2~ MT-2, Jurkat, and HUT-102 extracts were assayed as follows: ("C) chloramphenicol (0.2 pCi) was incubated with 0.7 mmol/L acetyl coenzyme A and SO pL of cell extract in a final volume of 150 pL of 0.25 mol/L Tris-HCL (pH 7.8) for 12 hours at 37°C. ("C) chloramphenicol was extracted with ethyl acetate and separated by chromatography on thin-layer plates. Each transfection was performed in duplicate and the results expressed as change in the percent acetylation of chloramphenicol as determined by densitometry.
PBL extracts were assayed using the scintillation method." Cell extract (50 pL) was heated to 65°C for 5 minutes and added to a 
RNA isolation.
RNase protection analysis. Protection analysis was used to quantitate CAT RNA transcripts. PBL (lo') were electroporated with 40 pg of either pU3RCAT or pCD1SCAT in the presence of pHD4 or pCMV. After 24 hours, 50% of the cells were removed for CAT assay and total cellular RNA was prepared from the remaining cells. A 500-bp region of the CAT coding sequence was cloned into the plasmid pT7T3 (Pharmacia, Piscataway, NJ) downstream from the T7 polymerase promoter. A 500-bp region of the p-actin sequence was cloned downstream from the T7 polymerase promoter as well. 32P-labeled antisense RNA probes were synthesized using the T7 polymerase. The gel-purified RNA probes (5 x 105 cpm) were hybridized to the total cellular RNA (20 pg). Digestion of the hybrid RNAwas performed with 40 U/mL of RNase A and 2 pg/mL of RNase T1 at 37°C for 1 hour. After termination of the digestion reactions with the addition of 10% sodium dodecyl sulfate and 50 pg/mL proteinase K, the reactions were extracted with phenol-chloroform and the "P-RNA/RNA hybrids were precipitated with ethanol. The protected hybrid RNA was analyzed by autoradiography on a 6% acrylamide gel containing 7 mol/L urea. Band intensity was quantified by densitometry. The quantity of CAT RNA was compared with p-actin RNA.
RESULTS
Products of HCMV IE-2 region repress pU3RCAT. We assessed the effect of the HCMV IE-2 region on HTLV-I promoter function by transfecting 40 pg of pU3RCAT plasmid with either 10 pg of pHD4 plasmid expressing the IE-2 gene under the control of the HCMV promoter or with the control plasmid, pCMV, containing the CMV promoterenhancer alone into HTLV-I-producing lines MT-2 and HUT-102 as well as in PBL. CAT activity from pU3RCAT was reduced threefold in the presence of pHD4 when compared to transfection with the control plasmid pCMV in HUT-102 cells (Fig 1) . When pU3RCAT was transfected into MT-2 or Jurkat cells with either pHD4 or pHDCR, containing the antisense orientation of exon 5, expression of IE-2 in proper orientation resulted in a twofold reduction in CAT activity relative to the antisense orientation. In contrast to its effects on pU3RCAT, cotransfection of pHD4 with the plasmid pCD12CAT, which contains the CAT gene driven by the HIV-1 promoter, resulted in at least a threefold increase in CAT activity in the same cell lines, similar to the findings reported by Davis et aL6 The results with the MT-2 cell lines are not shown but were identical.
Cotransfection experiments in primary PBL showed a consistent repressive effect of pHD4 on the HTLV-I LTR as indicated in Fig 2 and Table 1 . In triplicate experiments, the HCMV 1E-2 gene product showed at least a twofold repression of the HTLV-I promoter. There is a consistent upregulation of the HIV-1 LTR by HCMV IE-2 gene products in primary lymphocytes in the presence or absence of the tat-producing plasmid, ptat (Fig 2 and Table 1) . Therefore, the HCMV IE-2 region specifically repressed the HTLV-I promoter in both HTLV-I-producing cell lines where Tax, the major transactivating protein of HTLV-I, is expressed as well as in lymphocyte cell lines and PBL. This effect was in contrast to the consistent upregulation of the HIV-1 promoter by the same gene product(s).
RNase protection analysis of RNA in transfected PBLs. pHD4 and pU3RCAT was analyzed for specific CAT transcripts using RNase protection. In three separate experiments, RNA from PBL cotransfected with pHD4 and pU3RCAT showed a twofold reduction in CAT message compared with pU3RCAT cotransfected with pCMV (as determined by densitometry). This corrcsponded to a twofold reduction in CAT activity (Fig 2) . P-Actin expression was comparable in the same RNA sample. were sequentially eliminated were cotransfected with pHD4 into MT-2 cells there was a significant reduction in CAT activity when compared to transfection of the mutants with the control plasmid, pCMV (Fig 3) . As the deletions involved regions close to the mRNA start site the reduction persisted dcspite a decrease in basal expression. Because there was no discrctc responsive elements by 5' deletion analysis, 3' deletion mutants were examined to detcrmine if there was an HCMV TE-2 responsive region downstream of the mRNA start site. The results of the cotransfection experiments are shown in Fig 4. In all experiments there was a significant repression of HTLV-I LTR-driven CAT "The indicator plasmids pU3RCAT (40 pg) and pCD15CAT (30 pg) were cotransfected into primary blood lymphocytes with 10 pg of the ("c) acetylchloramphenicol activity is expressed in cpm x lo4 and represents the mean Of two to three transfections. The fold change in parentheses is the mean change in the presence of pHD4 compared with the baseline activity in the presence of the control plasmid pCMV. p g of the IE-Z-expressing plas-9 7 9 7 9 9 9 9 9 9 The repression of the HTLV-I LTR by HCMV IE-2 gene product(s) was associated with a decrease in specific level of CAT mRNA, which may reflect either a decrease in transcription or a decrease in the stability of the message. We have now shown in primary lymphocytes, and others have shown in cell lines,6 that products from this same HCMV region enhance gene expression from other heterologous promoters including HIV, thus suggesting that these observed effects represent specific interactions between the IE-2 gene products and the promoters. The previously reported enhanced expression of the HIV-1 promoter in the presence of IE-2 is also associated with an increase in specific RNA. 6 The LTR of HTLV-I has previously been shown to be trans-activated by Tax, the HTLV-I transactivator protein encoded by the pX region of HTLV-I genome. At least two of the three 21-bp imperfect repeats contained in the U3 region of the LTR are necessary for an optimal response to Recent evidence suggests that tux interacts indirectly with LTR sequences -117 to -163, located between two 21-bp repeats by binding to other cellular transcription Our deletion analysis showed that the specific tux-responsive elements of the HTLV-I LTR are not required to demonstrate repression by HCMV IE-2 in the MT-2 cell line. Using 3' deletions as well, there was no distinct region responsive to HCMV IE-2. Similar results were initially reported with attempts to map the regions of the HIV-1 and -2 promoters that are responsive to the upregulation associated with HCMV IE-2 protein^.^' However, more recently the IE-2-responsive element in the HIV promoter has been mapped between -6 and +7.33 Our deletion analysis does not exclude the possibility that a specific HCMV IE-Zresponsive element does lie within the region of the mRNA initiation site. The HCMV IE-2 product(s) effects on the promoter may be mediated through cellular intermediaries that have multiple binding domains.
Total cellular RNA extracted from PBL cotransfected with
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Effect of HCMV IE-2 gene products on 5' and 3' HTI-V-I LTR deletion mutants. The three 21-bp imperfect repeats required for transactivation of the HTLV-I promoter by
Deletion analysis also showed a putative negative element between +45 and +lo5 relative to the cap site that has not been previously described. As noted in Results (Fig  4) , baseline CAT activity was markedly decreased with deletion 3D, but further deletion resulted in a return to baseline CAT activity. This finding suggests the presence of a negative element(s) within this region that will be further characterized.
While the potential molecular interactions between different viruses have been clearly shown in vitro, only limited studies have supported the importance of these interactions in vivo." Nevertheless, such molecular studies provide the basis for more extensive epidemiologic studies of factors that might play a role in disease manifestations. This is particularly relevant in the case of HTLV-I-associated ATL and TSP-HAM, where factors such as genetic variability of virus isolates is minima1,34.35 and therefore other host factors must be examined to determine why the vast majority of infected patients do not develop disease. 
